Welcome to your regularly scheduled Friday edition of Dispensed, where we’re looking forward to the weekend after finally getting out our list of 30 leaders under 40 transforming healthcare. We hope you all have enjoyed the project as much as we enjoyed getting to know the honorees this summer. Click here to see the whole list.
But first, I wanted to quickly catch up on the drama surrounding Amazon’s online pharmacy PillPack.
Last week, I spent some time digging into the back-and-forth between the tech giant and health data company Surescripts over access to medication history information that Surescripts collects. Between threats of lawsuits and claims of reporting companies to the FBI, it’s sure escalated quickly.
That, combined with CNBC’s report Tuesday that PillPack has run into issues working with retail pharmacy giants Walgreens and CVS when trying to transfer over prescriptions, to me gets to the heart of a key issue facing the pharmacy industry: Who should be allowed to have what patient data, when?
I spoke with independent pharmacists to get some more context about how medication information is shared today and the pros and cons that come with having more data at your fingertips. Find out …read more
Source:: Businessinsider – Technology